Agilisium Earns 10th Consecutive Inc. 5000 Ranking, Cementing a Decade of Growth
India 25th August , 2026 – Agilisium, the world’s only Life Sciences Context-Centric AI Consulting & Services company, driving business transformation across the entire Molecule-to-Market value chain, today announced its recognition on the 2026 Inc. 5000 list of America’s fastest-growing private companies.
The recognition marks Agilisium’s 10th consecutive year on the prestigious list, reflecting a decade of sustained growth, disciplined execution, purpose-led innovation, and customer trust.
Over the past decade, Agilisium has evolved alongside major shifts in technology and customer expectations—from analytics and digital transformation to cloud, data, AI, and now Context-Centric AI for Life Sciences. Agilisium growth has been anchored in combining deep industry context with technology to solve complex challenges and deliver measurable outcomes across the Life Sciences value chain.
Continuing this evolution, Agilisium has introduced its Forward Deployment Experience (FDXe), bringing together Forward Deployment Experts, AI Agents, and Services to accelerate AI-led transformation. Powered by Alexandria AI, its AI-native capability orchestration and readiness engine, FDXe combines domain context, expertise, and agent infrastructure to help teams move from identified opportunities to working AI agents in approximately 60 days.
“Ten consecutive years on the Inc. 5000 represents far more than an annual ranking. It reflects the trust our customers place in our people, capabilities, and commitment to delivering meaningful outcomes, Our ability to continuously innovate, reinvent, and execute with discipline has been central to this journey, and I am deeply grateful to our people, customers, partners, and advisors who have made it possible” said Raj Babu, Founder and CEO of Agilisium.
“As a member of the founding team, I am incredibly proud of what this recognition represents—a decade of growth, reinvention, and trust built with our customers and people. As we look ahead, the next phase of AI will be defined by how effectively organizations translate intelligence into meaningful business impact. FDXe reflects how we are advancing that journey, bringing deep domain expertise, AI, and execution closer to business needs so that ideas can move faster and more consistently from innovation to scalable outcomes,” said Arun Kumar Arjunan, COO & CAIIO of Agilisium.
As Agilisium enters its next phase of growth, the company continues to focus on translating advances in AI into practical, scalable capabilities that bring domain expertise, technology, and execution closer to real business needs.
About Agilisium :
Agilisium is the world’s only Life Sciences Context-Centric AI Consulting & Services company, delivering transformation from Molecule to Market. By combining deep Life Sciences context with AI, data, analytics, cloud, and intelligent automation, Agilisium helps pharmaceutical, biotechnology, and medical technology organizations solve complex business challenges and achieve measurable outcomes.